Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Bupropion in children with attention deficit disorder.

Casat CD, Pleasants DZ, Schroeder DH, Parler DW.

Psychopharmacol Bull. 1989;25(2):198-201. No abstract available.

PMID:
2513592
2.

A double-blind trial of bupropion in children with attention deficit disorder.

Casat CD, Pleasants DZ, Van Wyck Fleet J.

Psychopharmacol Bull. 1987;23(1):120-2. No abstract available.

PMID:
3110853
3.

Bupropion effects in attention deficit and conduct disorders.

Simeon JG, Ferguson HB, Van Wyck Fleet J.

Can J Psychiatry. 1986 Aug;31(6):581-5.

PMID:
3093046
4.

Review of placebo-controlled trials with bupropion.

Zung WW.

J Clin Psychiatry. 1983 May;44(5 Pt 2):104-14.

PMID:
6406436
6.

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.

Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, Hampton KD, Richard NE, Modell JG.

Biol Psychiatry. 2005 Apr 1;57(7):793-801.

PMID:
15820237
7.

Change from Mg-pemoline to bupropion in a 12-year-old boy with attention-deficit hyperactivity disorder.

Bloomingdale LM.

J Clin Psychopharmacol. 1990 Oct;10(5):382-3. No abstract available. Erratum in: J Clin Psychopharmacol 1991 Apr;11(2):126.

PMID:
2124222
8.

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.

Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA; Modafinil ADHD Study Group.

J Clin Psychiatry. 2006 May;67(5):727-35.

PMID:
16841622
9.
10.

Evaluating drug effects on children's cognitive functioning.

Ferguson HB, Simeon JG.

Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(4-6):683-6.

PMID:
6442440
11.

A comparative study of bupropion and amitriptyline in depressed outpatients.

Mendels J, Amin MM, Chouinard G, Cooper AJ, Miles JE, Remick RA, Saxena B, Secunda SK, Singh AN.

J Clin Psychiatry. 1983 May;44(5 Pt 2):118-20.

PMID:
6406439
12.

Clinical profile of the novel antidepressant bupropion.

Stern WC, Harto-Truax N, Rogers J, Miller L.

Adv Biochem Psychopharmacol. 1982;32:21-34. No abstract available.

PMID:
6807060
13.

Fenfluramine treatment of childhood attention deficit disorder with hyperactivity: a preliminary report.

Donnelly M, Rapoport JL, Ismond DR.

Psychopharmacol Bull. 1986;22(1):152-4. No abstract available.

PMID:
3523573
14.

A double-blind comparison of bupropion and amitriptyline in depressed inpatients.

Davidson J, Miller R, Van Wyck Fleet J, Strickland R, Manberg P, Allen S, Parrott R.

J Clin Psychiatry. 1983 May;44(5 Pt 2):115-7.

PMID:
6406438
15.
16.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
17.

Safety and efficacy of bupropion in elderly patients: preliminary observations.

Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M.

J Clin Psychiatry. 1983 May;44(5 Pt 2):134-6.

PMID:
6406442
18.

Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, Holman TL, Moser DJ, Paulsen JS.

Ann Clin Psychiatry. 2001 Sep;13(3):129-34.

PMID:
11791949
19.

Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.

Feighner J, Hendrickson G, Miller L, Stern W.

J Clin Psychopharmacol. 1986 Feb;6(1):27-32.

PMID:
3081600
20.

Bupropion in depression: a tri-center placebo-controlled study.

Pitts WM, Fann WE, Halaris AE, Dressler DM, Sajadi C, Snyder S, Ilaria RL.

J Clin Psychiatry. 1983 May;44(5 Pt 2):95-100.

PMID:
6406473
Items per page

Supplemental Content

Write to the Help Desk